跳至主要内容
临床试验/ACTRN12616000951459
ACTRN12616000951459尚未招募1 期

Feasibility and effects of inorganic nitrate in acute decompensated heart failure

Western Health0 个研究点目标入组 40 人开始时间: 2016年7月19日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients presenting to the emergency department within the previous 24 hours, with a provisonal diagnosis with ADHF. Diagnosis is based on at least one of: dyspnoea, orthopnoea or oedema, and one sign of: chest crackles, peripheral oedema or ascites, and/or radiological confirmation of pulmonary vascular congestion on chest radiography. BNP and the boston criteria will also be used to refute and affirm true heart failure status.

排除标准

  • Patients will be excluded if they have a pre-existing need for inotrope therapy; an eGFR <20 mL/min/1.73m2 or on renal replacement therapy (i.e. dialysis); a baseline systolic blood pressure of < 110mmHg; relevant concomitant condition [haemoglobin of less than 10.0 gm/dL, critical aortic stenosis, isolated severe right sided heart failure, respiratory failure, cirrhosis of the liver (Child Pugh class C), advanced malignancy or advanced dementia]; women of child-bearing potential or nursing mothers, recent Sildenafil use (<24 hours on specific enquiry) or a history of Glucose-6-phosphate deficiency elicited on history or medical record search.

研究者

相似试验

Feasibility and effects of inorganic nitrate in... | 临床试验